Halozyme takes the win over MSD’s cancer drug Keytruda in the Netherlands
The Dutch court dismissed MSD’s revocation action against the Dutch part of EP 2 797 622 and granted Halozyme’s counterclaims for infringement in Belgium, Denmark, France, Ireland, Italy, the Netherlands, Sweden, and Switzerland (case ID: C/09/695432 / HA ZA 25-1075).